Saturday 17 October 2026
Export AEMD’s income statement to Excel — free account
Aethlon Medical, Inc.
AEMD Healthcare Medical Devices
Aethlon Medical, Inc.’s revenue for fiscal 2023 (year ended March 2023) was $574,200.00, up 95.2% from fiscal 2022. In the quarter to June 2026, EPS grew 90.5% and free cash flow fell 11.1%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
5.15
0.12
−2.28%
Follow AEMD
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (160.91%) | (142.89%) | (208.60%) | (191.38%) |
+8 more TTM periods Free account |
|
| (120.22%) | (104.46%) | (158.03%) | (139.25%) | ||
ROIC |
(1,665.51%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(142.51%) | (159.65%) | (182.35%) | (209.94%) | |
Average Days of Receivables |
— | — | — | 0.00 | |
Free Cash Flow per Share |
(18.70) | (52.00) | (42.15) | (88.77) | |
Free Cash Flow |
(7.20) | (7.01) | (6.94) | (7.06) | |
Capital Expenditures |
(0.02) | (0.01) | (0.02) | — | |
| Other line items | |||||
Cash ROIC |
(71.01%) | (70.71%) | (50.76%) | (60.84%) | |
Accounts Receivable Turnover |
— | — | — | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.04 | 0.98 | 0.60 | 0.63 | |
Depreciation/Fixed assets |
1.08 | 0.91 | 0.78 | 0.65 | |
Capex/Depreciation |
(0.05) | (0.03) | (0.05) | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(18.66) | (51.92) | (42.04) | (88.77) | |
Capex per Share |
(0.04) | (0.08) | (0.11) | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — |
Columns are period end dates